78 results
S-3
EX-1.2
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
, action, suit, audit, survey, proceeding, hearing, enforcement, investigation, arbitration or other action from any court or arbitrator or governmental
10-Q
2024 Q1
EX-31.2
MREO
Mereo Biopharma Group Plc
15 May 24
Quarterly report
4:19pm
evaluation of internal control over financial reporting, to the registrant’s auditors and the audit and risk committee of the registrant’s board
10-Q
2024 Q1
EX-31.1
MREO
Mereo Biopharma Group Plc
15 May 24
Quarterly report
4:19pm
recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit and risk committee of the registrant’s board
10-Q
2024 Q1
MREO
Mereo Biopharma Group Plc
15 May 24
Quarterly report
4:19pm
costs
Accrued legal fees
Accrued bonus
Accrued audit fees
Accrued professional fees
Accrued local taxes
Other accrued expenses
Total
10. Convertible
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
the conclusion of the next annual general meeting at which the Company’s annual report and accounts are presented.
That the Audit and Risk Committee … those expressly stated.
Website Publication of Audit Concerns
Under Section 527 of the Companies Act 2006, members meeting the threshold
10-K
EX-31.1
wgw5m
27 Mar 24
Annual report
5:20pm
10-K
EX-31.2
aixnvlw5rsk9
27 Mar 24
Annual report
5:20pm
10-K
e8kvj
27 Mar 24
Annual report
5:20pm
10-K
EX-10.30
1pe2kru16 bdxg
27 Mar 24
Annual report
5:20pm
6-K
z2yyd4nsgsb3bpv
20 Sep 23
Current report (foreign)
4:03pm
6-K
t22rd b6toplcl
10 Nov 22
Current report (foreign)
4:06pm
6-K
EX-99.2
nb1c32x
2 Nov 22
Current report (foreign)
4:17pm
6-K
EX-99.2
4rpfceyy92x
21 Oct 22
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
7:06am
6-K
7db9he
26 May 22
Current report (foreign)
4:11pm